Patents by Inventor Dana Wolfe

Dana Wolfe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230149418
    Abstract: The present invention provides compositions and methods for treating, preventing, and inhibiting viral replication, viral infections and viral diseases and disorders, comprising use of artemisone in combination with at least one antiviral compound selected from maribavir, cidofovir, brincidofovir, valganciclovir, and letermovir, and the combination provides a synergistic anti-viral effect. The invention also provides compositions and methods for treating, preventing, and inhibiting viral replication, viral infections and viral diseases and disorders, comprising the use of artemisone in combination with ganciclovir, wherein the molar ratio between artemisone and ganciclovir is about 1:100 to 100:1, and the combination provides a synergistic anti-viral effect. Pharmaceutical compositions comprising artemisone and at least one of said antiviral compounds are provided as well.
    Type: Application
    Filed: January 20, 2023
    Publication date: May 18, 2023
    Inventor: Dana WOLF
  • Patent number: 11583537
    Abstract: The present invention provides compositions and methods for treating, preventing, and inhibiting viral replication, viral infections and viral diseases and disorders, comprising use of artemisone in combination with at least one antiviral compound selected from maribavir, cidofovir, brincidofovir, valganciclovir, and letermovir, and the combination provides a synergistic anti-viral effect. The invention also provides compositions and methods for treating, preventing, and inhibiting viral replication, viral infections and viral diseases and disorders, comprising the use of artemisone in combination with ganciclovir, wherein the molar ratio between artemisone and ganciclovir is about 1:100 to 100:1, and the combination provides a synergistic anti-viral effect. Pharmaceutical compositions comprising artemisone and at least one of said antiviral compounds are provided as well.
    Type: Grant
    Filed: September 21, 2020
    Date of Patent: February 21, 2023
    Assignee: HADASIT MEDICAL RESEARCH SERVICES AND DEVELOPMENT LTD.
    Inventor: Dana Wolf
  • Publication number: 20230038224
    Abstract: The present invention provides biomarkers allowing the diagnosis of symptomatic congenital cytomegalovirus (CMV) infection and in particular to differentiate between symptomatic and asymptomatic infected fetuses, methods of diagnosis of CMV using said biomarkers, diagnostic kits comprising thereof, and use of the kits and methods of diagnosing fetuses infected with a symptomatic congenital cytomegalovirus (CMV).
    Type: Application
    Filed: July 29, 2022
    Publication date: February 9, 2023
    Inventor: Dana Wolf
  • Publication number: 20210000839
    Abstract: The present invention provides compositions and methods for treating, preventing, and inhibiting viral replication, viral infections and viral diseases and disorders, comprising use of artemisone in combination with at least one antiviral compound selected from maribavir, cidofovir, brincidofovir, valganciclovir, and letermovir, and the combination provides a synergistic anti-viral effect. The invention also provides compositions and methods for treating, preventing, and inhibiting viral replication, viral infections and viral diseases and disorders, comprising the use of artemisone in combination with ganciclovir, wherein the molar ratio between artemisone and ganciclovir is about 1:100 to 100:1, and the combination provides a synergistic anti-viral effect. Pharmaceutical compositions comprising artemisone and at least one of said antiviral compounds are provided as well.
    Type: Application
    Filed: September 21, 2020
    Publication date: January 7, 2021
    Inventor: Dana WOLF
  • Patent number: 7735150
    Abstract: A safety harness system to facilitate attachment and storage of a safety harness. The safety harness is secured to a garment to allow the safety harness to be removed and stored with the garment, thereby preventing entanglement and loss of the safety harness during removal and storage. By securing the safety harness to the garment, the safety harness is less likely to become tangled, lost or damaged during storage.
    Type: Grant
    Filed: September 19, 2007
    Date of Patent: June 15, 2010
    Inventor: Dana Wolfe
  • Publication number: 20090070912
    Abstract: A safety harness system to facilitate attachment and storage of a safety harness. The safety harness is secured to a garment to allow the safety harness to be removed and stored with the garment, thereby preventing entanglement and loss of the safety harness during removal and storage. By securing the safety harness to the garment, the safety harness is less likely to become tangled, lost or damaged during storage.
    Type: Application
    Filed: September 19, 2007
    Publication date: March 19, 2009
    Inventor: Dana Wolfe